N-Desmethyl imatinib

CAS No. 404844-02-6

N-Desmethyl imatinib( Norimatinib | Imatinib metabolite N-Desmethyl imatinib )

Catalog No. M26257 CAS No. 404844-02-6

N-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 179 In Stock
5MG 169 In Stock
10MG 319 In Stock
25MG 541 In Stock
50MG 761 In Stock
100MG 1051 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-Desmethyl imatinib
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
  • Description
    N-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Norimatinib | Imatinib metabolite N-Desmethyl imatinib
  • Pathway
    Angiogenesis
  • Target
    Bcr-Abl
  • Recptor
    Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    404844-02-6
  • Formula Weight
    479.588
  • Molecular Formula
    C28H29N7O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (208.52 mM)
  • SMILES
    Cc1ccc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1Nc1nccc(n1)-c1cccnc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kim B, et al. Differential effects of alkyl gallates on quorum sensing in Pseudomonas aeruginosa. Sci Rep. 2019;9(1):7741. Published 2019 May 23.
molnova catalog
related products
  • Dasatinib

    A potent, orally bioavailable, dual Src/Abl kinase inhibitor.

  • CHMFL-ABL-039

    CHMFL-ABL-039 is a type II native ABL kinase and drug-resistant V299L mutant BCR-ABL inhibitor (IC50s: 7.9 nM and 27.9 nM) used in the research of chronic myeloid leukemia.

  • PD180970

    PD180970 is an inhibitor of Bcr-Abl with IC50s of 5 nM, 0.8 nM and 50 nM for the autophosphorylation of p210Bcr-Abl, Src and Kit.